Share on Pinterest The condition eosinophilic esophagitis can make it difficult for children to eat. Westend61/Getty Images Researchers have published new research about eosinophilic esophagitis (EoE) ...

Elizabeth Spencer, MD, discusses various treatments for eosinophilic esophagitis (EoE) across age groups, highlighting the role of dietary modifications, proton pump inhibitors, swallowed ...

Antibiotic and acid suppressant exposure during the perinatal period was linked to the development of eosinophilic esophagitis (EoE) later in life, a Danish cohort study found. Infants with any ...

“Kids shouldn't have to struggle in silence,” the boy's mother said ...

The US Food and Drug Administration (FDA) has finalized a guidance for industry on development of drugs and therapeutic biologics for treating eosinophilic esophagitis (EoE), a chronic, allergic ...

While dupilumab's use has been extended to children under 12, benralizumab shows no benefit to patients with eosinophilic esophagitis (EoE). Despite high hopes, a drug that wipes out the namesake cell ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent, Regeneron/Sanofi) for the treatment of eosinophilic esophagitis (EoE) in children aged 1-11 years and weighing ≥ 15 kg. It ...

The FDA approved budesonide oral suspension (Eohilia) for adults and children ages 11 years and older with eosinophilic esophagitis (EoE), drugmaker Takeda announced. Approval of the 12-week course of ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted an orphan drug designation to ’1104 from Revolo Biotherapeutics, a first-in-class ...

The US Food and Drug Administration (FDA) issued draft guidance on Wednesday to aid sponsors in the clinical development of drugs and biologics for the treatment of eosinophilic esophagitis (EoE). The ...

(RTTNews) - British drug major AstraZeneca Plc. (AZN, AZN.L) announced Friday that the U.S. Food and Drug Administration or FDA has granted Orphan Drug Designation to Tezepelumab for the treatment of ...

The 3 main treatments for EoE are medication, dietary therapy, or mechanical dilation of the esophagus. Patients should be evaluated individually to address their most problematic complaints first, ...